SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drugs - Quaterly Results

12 Feb 2026 Evaluate
The sales declined to Rs. 221.84 millions for the December 2025 quarter as compared to Rs. 295.52 millions during the corresponding quarter last year.The Company's Net profit for the December 2025 quarter have declined marginally to Rs. 7.58  millions as against Rs. 7.67 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 24.94 millions from 26.75 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 221.84 295.52 -24.93 726.44 878.48 -17.31 1133.50 1567.12 -27.67
Other Income 0.16 0.98 -83.67 6.63 8.72 -23.97 9.77 6.18 58.09
PBIDT 24.94 26.75 -6.77 80.39 95.87 -16.15 128.04 139.22 -8.03
Interest 11.11 11.10 0.09 30.24 36.25 -16.58 47.32 49.15 -3.72
PBDT 16.34 15.65 4.41 52.66 59.62 -11.67 80.72 89.17 -9.48
Depreciation 6.12 6.44 -4.97 18.20 17.76 2.48 24.48 19.95 22.71
PBT 10.22 9.21 10.97 34.46 41.86 -17.68 56.24 69.22 -18.75
TAX 2.64 1.54 71.43 6.47 6.99 -7.44 12.45 13.73 -9.32
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.58 7.67 -1.17 27.99 34.87 -19.73 43.79 55.49 -21.08
Equity 75.30 75.30 0.00 75.30 75.30 0.00 75.30 75.30 0.00
PBIDTM(%) 11.24 9.05 24.20 11.07 10.91 1.40 11.30 8.88 27.15

Godavari Drugs Share Price

125.15 7.44 (6.32%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×